Skip to main content

Table 3 Risk ratios of adverse events and mortalities among stroke patients

From: Autologous bone-marrow mononuclear stem cell therapy in patients with stroke: a meta-analysis of comparative studies

Adverse event

No. of studies

No. of patients

Model (H %)

RR [95% CI]

P

Partial seizures

3

120

F (0)

2.05 [0.74, 5.73]

0.17

Fever

3

240

F (0)

1.57 [0.69, 3.58]

0.29

Infection

4

218

F (12)

1.56 [0.78, 3.12]

0.21

Recurrent vascular episodes

4

259

F (27)

2.11 [0.73, 6.13]

0.17

Malignancy

2

148

F (33)

0.45 [0.08, 2.60]

0.37

Death

3

192

F (47)

0.81 [0.47, 1.38]

0.44

  1. CI confidence interval, F a fixed-effects model, H heterogeneity, RR risk ratio